Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Oramed Pharmaceuticals Inc. (ORMP)

Compass Therapeutics, Inc. and Oramed Pharmaceuticals Inc. are both Biotechnology companies. Compass Therapeutics, Inc. and Oramed Pharmaceuticals Inc. are of similar size ($173.9M and $161.5M). Compass Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 1.0×. Across the 10 metrics below, Oramed Pharmaceuticals Inc. leads on 7 and Compass Therapeutics, Inc. on 3.

Valuation

Metric CMPX ORMP Biotechnology median
P/E n/m 0.96 8.50
P/S n/m 41.54 9.71
P/B 0.97 0.53 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 n/m 0.64
EV/Sales n/m 28.95 9.21
Earnings yield (46.51%) 103.93% (33.15%)
Free cash flow yield (35.09%) (3.12%) (25.50%)

Profitability

Metric CMPX ORMP Biotechnology median
Gross margin 0.00% 32.31% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.66%) 73.90% (56.36%)
Return on assets (47.87%) 65.52% (48.04%)
Return on invested capital 0.00% (3.40%) 0.00%

Growth

Metric CMPX ORMP Biotechnology median
Revenue growth (TTM) — 347.77% 6.02%
EPS growth (last fiscal year) (16.67%) 412.50% 30.26%
Revenue growth, 5-year CAGR — (5.85%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX ORMP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 4.98 4.72
Net debt to EBITDA 2.86 8.41 0.96

Dividend

Metric CMPX ORMP Biotechnology median
Dividend yield — 6.14% 0.09%
Payout ratio — 0.06 —

Size

Metric CMPX ORMP Biotechnology median
Market cap 161.49m 173.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack